Literature DB >> 31486474

Let-7 participates in the regulation of inflammatory response in spinal cord injury through PI3K/Akt signaling pathway.

J Tang1, W-C Guo, J-F Hu, L Yu.   

Abstract

OBJECTIVE: To study the potential mechanism of let-7 in participating in the regulation of inflammatory response in spinal cord injury (SCI).
MATERIALS AND METHODS: A total of 40 male Sprague-Dawley rats were randomly divided into four groups: group A (Sham, n=10), group B (SCI+NC, n=10), group C (SCI+antagomir, n=10), and group D (SCI+mimics, n=10). The SCI model was established via operation in all groups. After successful modeling, let-7-antagomir negative control (80 mg/kg) was intraperitoneally injected in SCI+NC group at 5 d, an equal amount of let-7-antagomir was intraperitoneally injected in SCI+antagomir group at 5 d, and an equal amount of let-7-mimics was intraperitoneally injected in SCI+mimics group at 5 d. The inflammatory cells in experimental groups and control group were observed via hematoxylin-eosin (HE) staining. At the same time, the expression of let-7 in the four groups was detected via Reverse Transcription-Polymerase Chain Reaction (RT-PCR), the expressions of phosphatidylinositol 3-hydroxy kinase (PI3K) and protein kinase B (Akt) in all groups were detected via Western blotting, and the inflammatory index levels in each group were detected via enzyme-linked immunosorbent assay (ELISA).
RESULTS: In Sham group, it was observed via HE staining that there were only a few bleeding or inflammatory cells. In SCI+NC group, bleeding and inflammatory cells basically tended to be stable. There were a large number of inflammatory cells in SCI+mimics group, while there were some inflammatory cells in SCI+antagomir group, but showing a decreasing trend compared with SCI+NC group. It was found in the RT-PCR detection of let-7 expression level in all groups that the expression of let-7 significantly declined in SCI+antangomir group compared with that in Sham group and SCI+NC group, and there were significant differences (p<0.01). The expression of let-7 was significantly increased in SCI+mimics group compared with that in Sham group and SCI+NC group, and there were significant differences (p<0.01). The results of Western blotting revealed that the PI3K and Akt protein expressions were significantly decreased in SCI+mimics group compared with those in SCI+antagomir group, SCI+NC group, and Sham group (p<0.05). The ELISA results showed that the levels of inflammatory factors in SCI+mimics group, SCI+antagomir group, and SCI+NC group were significantly higher than those in Sham group. In SCI+mimics group, the levels of inflammatory factors were abnormally high and reached extremely significant levels (p<0.05), indicating that let-7 promotes the inflammatory response after SCI.
CONCLUSIONS: Let-7 participates in the regulation of inflammatory response in SCI through the PI3K/Akt signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31486474     DOI: 10.26355/eurrev_201908_18714

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  Identification of Regeneration and Hub Genes and Pathways at Different Time Points after Spinal Cord Injury.

Authors:  Sheng Fang; An-Quan Wang; Lin Zhong; Hui Zhang; Zong-Sheng Yin
Journal:  Mol Neurobiol       Date:  2021-01-23       Impact factor: 5.590

2.  Cytokine expressions of spinal cord injury treated by neurotropin and nafamostat mesylate.

Authors:  Chao Sun; Bo Li; Huiquan Duan; Bo Tao; Chenxi Zhao; Wenxiang Li; Yilin Pang; Baoyou Fan; Shiqing Feng
Journal:  Ann Transl Med       Date:  2021-03

3.  Gypenoside XVII protects against spinal cord injury in mice by regulating the microRNA‑21‑mediated PTEN/AKT/mTOR pathway.

Authors:  Tianyu Sun; Liying Duan; Jiaju Li; Hongyu Guo; Mingyue Xiong
Journal:  Int J Mol Med       Date:  2021-06-16       Impact factor: 4.101

4.  Down-regulation of miR-let-7e attenuates LPS-induced acute lung injury in mice via inhibiting pulmonary inflammation by targeting SCOS1/NF-κB pathway.

Authors:  Wuquan Li; Wentao Zhang; Jun Liu; Yalong Han; He Jiang; Gang Ji; Wenjun Liu
Journal:  Biosci Rep       Date:  2021-01-29       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.